DK0983059T3 - Fremgangsmåde til fremstilling af flurbiprofen sugetabletter - Google Patents

Fremgangsmåde til fremstilling af flurbiprofen sugetabletter

Info

Publication number
DK0983059T3
DK0983059T3 DK98929394T DK98929394T DK0983059T3 DK 0983059 T3 DK0983059 T3 DK 0983059T3 DK 98929394 T DK98929394 T DK 98929394T DK 98929394 T DK98929394 T DK 98929394T DK 0983059 T3 DK0983059 T3 DK 0983059T3
Authority
DK
Denmark
Prior art keywords
preparation
flurbiprofen
lozenges
flurbiprofen lozenges
Prior art date
Application number
DK98929394T
Other languages
English (en)
Inventor
Andrew Day
Huw Lyn Jones
Carl Simon Smith
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Application granted granted Critical
Publication of DK0983059T3 publication Critical patent/DK0983059T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98929394T 1997-05-22 1998-05-20 Fremgangsmåde til fremstilling af flurbiprofen sugetabletter DK0983059T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710521.7A GB9710521D0 (en) 1997-05-22 1997-05-22 Process
PCT/EP1998/003167 WO1998052539A1 (en) 1997-05-22 1998-05-20 Process for making flurbiprofen lozenges

Publications (1)

Publication Number Publication Date
DK0983059T3 true DK0983059T3 (da) 2003-11-03

Family

ID=10812840

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98929394T DK0983059T3 (da) 1997-05-22 1998-05-20 Fremgangsmåde til fremstilling af flurbiprofen sugetabletter

Country Status (31)

Country Link
US (1) US6194003B1 (da)
EP (1) EP0983059B1 (da)
JP (1) JP2001527567A (da)
KR (1) KR20010012739A (da)
CN (1) CN1154480C (da)
AR (1) AR015812A1 (da)
AT (1) ATE245021T1 (da)
AU (1) AU725760B2 (da)
BG (1) BG103881A (da)
BR (1) BR9809651A (da)
CA (1) CA2290830C (da)
CZ (1) CZ290816B6 (da)
DE (1) DE69816440T2 (da)
DK (1) DK0983059T3 (da)
ES (1) ES2202871T3 (da)
GB (1) GB9710521D0 (da)
HU (1) HU224954B1 (da)
ID (1) ID22949A (da)
IL (1) IL132999A0 (da)
IN (1) IN187837B (da)
MY (1) MY118410A (da)
NO (1) NO995681L (da)
NZ (1) NZ500664A (da)
PL (1) PL190947B1 (da)
PT (1) PT983059E (da)
RU (1) RU2203046C2 (da)
SK (1) SK283701B6 (da)
TR (1) TR199902725T2 (da)
UA (1) UA53714C2 (da)
WO (1) WO1998052539A1 (da)
ZA (1) ZA984260B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4040878B2 (ja) 1999-12-09 2008-01-30 レキット ベンキーザー ヘルスケア (ユーケイ) リミテッド 治療薬
AU2001257022B2 (en) * 2000-04-13 2005-02-03 Mayo Foundation For Medical Education And Research Abeta 42 lowering agents
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
AU2004311577A1 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
MXPA06012165A (es) * 2004-04-29 2007-01-17 Keystone Retaining Wall System Chapas para muros, muros de contencion y similares.
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
AU2006211023B2 (en) 2005-02-03 2012-05-24 Takeda Nycomed As Fast wet-massing method for the preparation of calcium-containing compositions
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
KR20080039876A (ko) * 2005-07-22 2008-05-07 미리어드 제네틱스, 인크. 높은 약물 충진 제형 및 투여형
JP2009514857A (ja) * 2005-11-02 2009-04-09 テイコク ファーマ ユーエスエー インコーポレーテッド 感覚器官的に許容されるイブプロフェン経口投与用製剤、該製剤の製法並びに使用法
WO2008006099A2 (en) * 2006-07-07 2008-01-10 Myriad Genetics, Inc. Treatment of psychiatric disorders
US20090028802A1 (en) * 2007-07-23 2009-01-29 Toru Hibi Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same
CA2733180A1 (en) * 2008-08-22 2010-02-25 Reckitt Benckiser Healthcare (Uk) Limited Improvements in or relating to compositions
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
IT1406107B1 (it) * 2010-12-13 2014-02-14 Alfa Wassermann Spa Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso.
EP3173069A1 (en) 2011-04-29 2017-05-31 Moberg Pharma AB Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat
EP2609911A1 (en) * 2011-12-29 2013-07-03 Sanovel Ilac Sanayi ve Ticaret A.S. A novel process for preparing orally disintegrating flurbiprofen formulations
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
JP6315741B2 (ja) * 2015-08-18 2018-04-25 合同会社Pharma Seeds Create NSAIDsまたはヘパリン類含有口腔用組成物
WO2020013781A2 (en) * 2018-03-27 2020-01-16 Pisak Mehmet Nevzat Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
US5302394A (en) 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US5614207A (en) * 1995-06-30 1997-03-25 Mcneil-Ppc, Inc. Dry mouth lozenge
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
MY118410A (en) 2004-10-30
IN187837B (da) 2002-06-29
DE69816440T2 (de) 2004-05-13
SK283701B6 (sk) 2003-12-02
NO995681D0 (no) 1999-11-19
NO995681L (no) 1999-11-19
PL190947B1 (pl) 2006-02-28
JP2001527567A (ja) 2001-12-25
WO1998052539A1 (en) 1998-11-26
PL336624A1 (en) 2000-07-03
AU725760B2 (en) 2000-10-19
EP0983059B1 (en) 2003-07-16
IL132999A0 (en) 2001-03-19
CN1255848A (zh) 2000-06-07
CA2290830C (en) 2006-07-11
CN1154480C (zh) 2004-06-23
PT983059E (pt) 2003-11-28
HUP0002121A2 (hu) 2000-12-28
ID22949A (id) 1999-12-16
HU224954B1 (en) 2006-04-28
CZ412099A3 (cs) 2000-02-16
BR9809651A (pt) 2000-07-11
NZ500664A (en) 2001-01-26
EP0983059A1 (en) 2000-03-08
US6194003B1 (en) 2001-02-27
TR199902725T2 (xx) 2000-02-21
ES2202871T3 (es) 2004-04-01
DE69816440D1 (de) 2003-08-21
SK158899A3 (en) 2000-05-16
CZ290816B6 (cs) 2002-10-16
RU2203046C2 (ru) 2003-04-27
KR20010012739A (ko) 2001-02-26
AU7916598A (en) 1998-12-11
ATE245021T1 (de) 2003-08-15
AR015812A1 (es) 2001-05-30
HUP0002121A3 (en) 2001-04-28
GB9710521D0 (en) 1997-07-16
ZA984260B (en) 1999-02-20
BG103881A (en) 2000-05-31
UA53714C2 (uk) 2003-02-17
CA2290830A1 (en) 1998-11-26

Similar Documents

Publication Publication Date Title
DK0983059T3 (da) Fremgangsmåde til fremstilling af flurbiprofen sugetabletter
DK1032566T5 (da) Fremgangsmåde til fremstilling af citalopram
DK0770615T3 (da) Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
DK1038008T3 (da) Fremgangsmåde til fremstilling af EGIII-lignende enzymer
DK0747116T3 (da) Fremgangsmåde til fremstilling af mikrokapselsammensætninger
DK1123284T3 (da) Fremgangsmåde til fremstilling af citalopram
DK0790226T3 (da) Fremgangsmåde til fremstilling af methanol
DK1005517T3 (da) Fremgangsmåde til fremstilling af diglycerider
DK0812845T3 (da) Fremgangsmåde til fremstilling af sildenafil
DK1008577T3 (da) Fremgangsmåde til fremstilling af methanol
DK1140886T3 (da) Fremgangsmåde til fremstilling af 5-cyanophtalid
DK0775100T3 (da) Fremgangsmåde til fremstilling af trifluorethylen
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DK1053217T3 (da) Fremgangsmåde til fremstilling af n-propanol
DK0996642T3 (da) Fremgangsmåde til fremstilling af heparin
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DK1027315T3 (da) Fremgangsmåde til fremstilling af n-butanol
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
DK0873326T3 (da) Fremgangsmåde til fremstilling af 2-chlorthiazolforbindelser
DK0912603T3 (da) Fremgangsmåde til fremstilling af visse azacyclohexapeptider
DK0970939T3 (da) Fremgangsmåde til fremstilling af methanol
DK0880498T3 (da) Fremgangsmåde til fremstilling af diketonforbindelser
DK0927766T3 (da) Enzymatisk fremgangsmåde til fremstilling af (S)-cyanhydriner
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater